Els Vandecasteele

Els Vandecasteele

Auto-generated profile, based on publicly available information

Els Vandecasteele

Department of Cardiology, Ghent University Hospital , Corneel Heymanslaan 10, 9000 Ghent

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2022 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
SDSebastiaan Dhont
Sebastiaan Dhont
BZBert Zwaenepoel
Bert Zwaenepoel
EVEls Vandecasteele
Els Vandecasteele
GBGuy Brusselle
Guy Brusselle
MPMichel De Pauw
Michel De Pauw
Pulmonary hypertension (PH) is present in an important proportion of patients with interstitial lung diseases (ILDs), encompassing a large, heterogeneous group of diffuse parenchymal lung diseases. Development of ILD-related PH is associated with reduced exercise capacity, increased need for supplemental oxygen, decreased quality of life and earlier death. Diagnosis of ILD-related PH is important and requires a high index of suspicion. Noninvasive diagnostic assessment can suggest the presence of PH, although right heart catheterisation remains the gold standard to confirm the diagnosis and to assess its severity. A comprehensive assessment is needed to make sure reversible causes of PH have been ruled out, including thromboembolic events, untreated hypoxaemia and sleep disordered breathing. The results of trials concerning pulmonary vasodilators in this particular patient group have been disappointing and, in some cases, were even associated with an increased risk of harm. Newer strategies such as medications administered through inhalation and combinations with antifibrotic drugs show encouraging results. Moreover, unravelling the role of the vasculature in the pathophysiology of pulmonary fibrosis and ILD-related PH may potentially unlock new therapeutic opportunities.

15 August 2019 in The Journal of Rheumatology
Verified
Journal Article
Closed access
VSVanessa Smith
Vanessa Smith
AVAmber Vanhaecke
Amber Vanhaecke
EVEls Vandecasteele
Els Vandecasteele
MGMiguel Pedro Guerra
Miguel Pedro Guerra
SPSabrina Paolino
Sabrina Paolino
MCMaurizio Cutolo
Maurizio Cutolo
Objective.: Pulmonary arterial hypertension (PAH) is one of the leading causes of death in systemic sclerosis (SSc). Current screening algorithms are hampered by low positive predictive values. Outcome measures that could add to performance characteristics would be welcome. We aim to evaluate the role of nailfold videocapillaroscopy (NVC) using standardized definitions, in SSc-related PAH (SSc-PAH).Methods.: A systematic review to identify original research papers documenting an association between NVC and right heart catheterization-defined SSc-PAH was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Subsequently, NVC characteristics were subdivided into quantitative (capillary density, dimension, morphology, and hemorrhages), semiquantitative, and qualitative assessment (NVC pattern), according to the definitions of the European League Against Rheumatism Study Group on Microcirculation in Rheumatic Diseases.Results.: The systematic search identified 316 unique search results, of which 5 were included in the final qualitative analysis. The occurrence of incident SSc-PAH unequivocally associated in 2 longitudinal studies with progressive capillary loss (p = 0.04 and p = 0.033) and the progression to a severe (active/late) NVC pattern (p = 0.05/0.01 and HR = 5.12, 95% CI 1.23–21.27). In 3 cross-sectional studies, SSc-PAH was found to be unequivocally inversely associated with capillary density (p = 0.001 and p < 0.05) and associated with the presence of a severe NVC pattern (p = 0.03 and p < 0.05).Conclusion.: This is the first systematic literature review investigating the role of NVC in SSc-PAH using standardized description, to our knowledge. Unequivocal associations were found between (incident) SSc-PAH and capillary density and NVC pattern. Integration of NVC into current screening algorithms to boost their performance may be a future step.

1 July 2018 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
GPGrégory Pugnet
Grégory Pugnet
ZMZora Marjanovic
Zora Marjanovic
CDChristophe Deligny
Christophe Deligny
KBKarine Boussardon
Karine Boussardon
IBIlham Benzidia
Ilham Benzidia
DFDominique Farge
Dominique Farge
Objective.: To assess the reproducibility and the utility of the 6-minute walk test (6MWT) in systemic sclerosis (SSc).Methods.: All patients with SSc who underwent at least two 6MWT within a minimum 3-month interval plus simultaneous routine clinical, biological, and functional evaluations were consecutively enrolled in this observational study over 6 years. Following American Thoracic Society guidelines, each 6MWT was repeated twice to assess the 6-minute walk distance (6MWD) reproducibility, with the highest value being reported for subsequent analysis.Results.: Among 56 (38 female) included patients aged 46 ± SD 12.7 years, with 17 ± 10 modified Rodnan skin score (mRSS) and 1 ± 0.8 Scleroderma Health Assessment Questionnaire (SHAQ) at first referral, 277 6MWT evaluations (5 ± 3.9 6MWT per patient) were performed over 23 ± 22.5 months followup. Meanwhile, 8 deaths (87.5% SSc-related) occurred. The mean 6MWD absolute value was 457 ± 117 m with a 4 ± 2.2 mean Borg dyspnea score. The 6MWD intraclass correlation coefficient was 0.996 (95% CI 0.995–0.999, p < 0.0001). In multivariate linear regression analysis, these factors were independently associated with a lower 6MWD: sex (R2 = 0.47, p < 0.0001), mRSS (R2 = 0.47, p = 0.008), tendon friction rub (R2 = 0.47, p = 0.003), SHAQ (R2 = 0.47, p = 0.02), muscle disability score (R2 = 0.47, p = 0.03), DLCO% (R2 = 0.47, p = 0.0008), and left ventricular ejection fraction (R2 = 0.47, p = 0.006). The 6MWD at first referral was an independent predictor for the overall mortality (HR 0.99, 95% CI 0.988–0.999) and the SSc-related mortality (HR 0.99, 95% CI 0.988–0.999).Conclusion.: We show strong reproducibility for the 6MWD and confirm the 6MWT utility to assess the overall prognosis of patients with SSc.

18 July 2016
Verified
Journal Article
Closed access
KMKarin Melsens
Karin Melsens
FKFilip De Keyser
Filip De Keyser
SDSaskia Decuman
Saskia Decuman
GBGuy Brusselle
Guy Brusselle
MPMichel De Pauw
Michel De Pauw
VSVanessa Smith
Vanessa Smith

4 December 2017 in Acta Clinica Belgica
Verified
Journal Article
Open access
RPRuben Pauwels
Ruben Pauwels
EVEls Vandecasteele
Els Vandecasteele
DDDaniel Devos
Daniel Devos
WPWalter Pauwels
Walter Pauwels
MPMichel De Pauw
Michel De Pauw
Juvenile hemochromatosis is a rare but severe form of hereditary hemochromatosis that typically presents early in life and can be fatal if left untreated.We present the case of a 30-year-old man wi...

1 June 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
AVA. Vanhaecke
A. Vanhaecke
VSVanessa Smith
Vanessa Smith
SPSabrina Paolino
Sabrina Paolino
KMK. Melsens
K. Melsens
YPY. Piette
Y. Piette
MCMaurizio Cutolo
Maurizio Cutolo
Background At this very moment, no systematic review evaluating the role of nailfold videocapillaroscopy (NVC) with standardised definitions, in interstitial lung disease (ILD) has been published. Objectives To systematically identify and review all available literature evaluating the role of NVCin ILD in SSc, according to the definitions of the EULAR study group on microcirculation in Rheumatic diseases. Methods A systematic literature search was performed in Pubmed, EMBASE and Web of Science. All retrieved articles were screened on title, abstract and full-text level. Reference lists and google scholar were additionally searched. Original research papers that documented an association between NVC and ILD in SSc were included. Subsequently, NVC parameters were subdivided in quantitative (density, dimension, morphology and haemorrhages), semi-quantitative (NVC score) and qualitative assessment (presence, severity and worsening of scleroderma pattern). Results The systematic search identified 299 unique search results, of which 145 references were withheld after title screening. Abstract screening resulted in 39 references, only 16 were eligible for full-text review. Finally, 16 references were included in the final analysis after full-text screening (n=13) and bibliographic and google scholar search (n=3) (see table 1). Regarding cross-sectional studies, density has been evaluated in 5 studies and has been unequivocally associated with DLCO/AV, DLCO, FVC and inversely with GGO. Dimension has been evaluated in 4 studies, with no unequivocal results. Morphology has been evaluated in 1 study and has been unequivocally associated with HC on HRCT. Haemorrhages have not been evaluated. NVC score has been evaluated in 2 studies and has been unequivocally associated with GGO on HRCT and total lung score. Presence of scleroderma pattern has been evaluated in 3 studies and has been unequivocally associated with reduction of DLCO and severe lung involvement. Severity of scleroderma pattern has been evaluated in 4 studies and has been unequivocally associated with reduction of DLCO and FVC, ILD on chest X-ray and lung involvement. Regarding longitudinal studies, density has been evaluated in 2 studies and has been unequivocally associated with reduction of DLCO. Dimension, morphology and haemorrhages have all been evaluated in 1 study, with no association. NVC score has not been evaluated. Presence of scleroderma pattern has been evaluated in 2 studies and has been unequivocally associated with reduction of DLCO, ILD on HRCT and future severe lung involvement. Worsening of scleroderma pattern has been evaluated in 1 study and has been unequivocally associated with future lung involvement. Conclusions This systematic literature review, on behalf of the EULAR study group on microcirculation in Rheumatic diseases, is the first to investigate unequivocal associations between ILD and capillaroscopic alterations in a standardised way. Unequivocal associations were found in cross-sectional studies between density, morphology, NVC score, presence and severity of scleroderma pattern and in longitudinal studies between density, presence and worsening of scleroderma pattern and ILD-defining parameters in SSc patients. References [1] De Santis M. Auto Immun Highlights.2016; [2] Sato LT. Acta Reumatol Port.2009; [3] Pizzorni C. J Rheum.2017; [4] Castellvi I. J Rehum.2015; [5] Hissaria P. Int J Med.2011; [6] Avouac J. Sermin Arthritis Rheum.2017; [7] Bredemeier M. J Rheum.2004; [8] Indiveri F. Ann Ital Med Int. 1999; [9] Medsger TA. Clin Exp Rheum.2003; [10] Fichel F. Dermatology.2014; [11] Smith V. Rheumatology.2012; [12] Ghizzoni C. Microvasc Res.2015; [13] Ingegnoli F. Microvasc Res.2013; [14] Jehangir M. Int J Res Med Sci.2015; [15] Markusse IM. Rheumatology2017; [16] Caramaschi P. Rheumatology.2007; [17] Claverie ML. Clin Rheumatol. 2013 Disclosure of Interest None declared